Human antibody–Fc receptor interactions illuminated by crystal structures

@article{Woof2004HumanAR,
  title={Human antibody–Fc receptor interactions illuminated by crystal structures},
  author={Jenny M. Woof and Dennis R. Burton},
  journal={Nature Reviews Immunology},
  year={2004},
  volume={4},
  pages={89-99}
}
  • J. WoofD. Burton
  • Published 1 February 2004
  • Biology, Medicine
  • Nature Reviews Immunology
Immunoglobulins couple the recognition of invading pathogens with the triggering of potent effector mechanisms for pathogen elimination. Different immunoglobulin classes trigger different effector mechanisms through interaction of immunoglobulin Fc regions with specific Fc receptors (FcRs) on immune cells. Here, we review the structural information that is emerging on three human immunoglobulin classes and their FcRs. New insights are provided, including an understanding of the antibody… 
View on Springer
ncbi.nlm.nih.gov
368 Citations
Highly Influential Citations
26
Background Citations
158
Methods Citations
1
Results Citations
5

368 Citations

Immunoglobulin–Fc Receptor Interactions

Immunoglobulins and their receptors, and subversion of their protective roles by bacterial pathogens.

  • J. Woof
  • Biology, Medicine
    Biochemical Society transactions
  • 2016
All the Ig-binding proteins studied in detail to date are seen to target the CH2-CH3 domain interface in the Ig Fc region, suggesting a common mode of immune evasion.

Are Receptors for IgA and IgG Cutting Edge: Human FcRL4 and FcRL5

Given their expression on activated B cells and potential for inhibitory signaling, Fc RL4 and FcRL5 are likely to be important for immune complex-dependent human B cell regulation, and they represent novel therapeutic targets for receptor blockade therapies.

Affimer proteins inhibit immune complex binding to FcγRIIIa with high specificity through competitive and allosteric modes of action

The identification of functionally specific protein-based inhibitors (Affimer proteins) of FcγRIIIa and the structural/functional basis of their selectivity suggest that highly selective protein- based blocking agents that may have therapeutic applications can be readily produced.

CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity

Virus-encoded FcγRs are discussed as the first known HCMV inhibitors of IgG-mediated immunity which could account for the limited efficacy of H CMV hyperimmune globulin in clinical settings and a better understanding of their molecular mode of action opens up new perspectives for improving IgG therapies against HCMv disease.

Isotype and glycoform selection for antibody therapeutics.

  • R. Jefferis
  • Biology
    Archives of biochemistry and biophysics
  • 2012

Cutting Edge: Human FcRL4 and FcRL5 Are Receptors for IgA and IgG

Given their expression on activated B cells and potential for inhibitory signaling, Fc RL4 and FcRL5 are likely to be important for immune complex-dependent human B cell regulation, and they represent novel therapeutic targets for receptor blockade therapies.

The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity

FcαRI acts as a regulator between anti- and proinflammatory responses of IgA, and its multifaceted role in immunity will be the focus of this review.

Antibody–receptor interactions mediate antibody-dependent cellular cytotoxicity

Identification of a linear epitope for Fc-binding in the mouse FcγRIII

...

References

SHOWING 1-10 OF 122 REFERENCES

Crystal structure of the human leukocyte Fc receptor, FcγRIIa.

The three–dimensional structure of the extracellular portion of human FcγRIIa to 2.0 Å resolution is determined providing a structural basis for the unique functions of the leukocyte FcR family.

Recognition of immunoglobulins by Fcγ receptors

Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease.

Expansion in knowledge of structure-function relationships among Fc gammaR has identified them as heritable risk factors for disease susceptibility and valuable targets for therapeutic modulation of the immune system.

Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.

The obtained models are consistent with the observed biochemical data and may explain the observed specificity and affinities of Fcgamma-receptors.

Crystal structure of the extracellular domain of a human Fc gamma RIII.

Localization of the binding site for the human high-affinity Fc receptor on IgG

This work has engineered a single amino acid change in a mouse IgG2b antibody which enables the antibody to bind to the FcRI (high affinity) receptor on human monocytes with a 100-fold improvement in affinity, indicating that Leu 235 is a major determinant in the binding of antibody to F cRI.

The IgG Binding Site of Human FcRIIIB Receptor Involves CC′ and FG Loops of the Membrane-proximal Domain (*)

The IgG binding site on human FcRIII is defined and residues map on the CC′ loop, on F β-sheet, and on the FG loop (Lys, Val) are found, suggesting that common structural determinants, i.e. FG loop or the GFC surface of the membrane-proximal domain, can be involved in interactions with IgG by both low affinity receptor classes F cRII and Fc RIII.

Interaction of Human IgE with Fc Epsilon RI Alpha Exposes Hidden Epitopes on IgE

The hypothesis of a conformational change within IgE Cε3 upon receptor binding is supported by showing that monoclonal antibodies raised against recombinant C ε3 differently recognize soluble and receptor–bound IgE.

Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.

Crystal structure of the soluble form of the human Fcγ‐receptor IIb: a new member of the immunoglobulin superfamily at 1.7 Å resolution

The crystal structure of the soluble human Fcγ‐receptor IIb (sFcγRIIb) is solved to 1.7 Å resolution and a model for the sFcαG:IgG complex is discussed, by which potential immunosuppressing functions could be mediated.
...